EDGE PharmaTech
ActiveSummary
EDGE PharmaTech has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,813 and a net result of €62,813. Equity is shrinking by about 27% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 14% of 11,583 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 13 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21616A0174/00D020 | Brussels | 282 m² | 1 · 79 m² | 12.4 m · 3 |
| 21618B0277/00S021 | Brussels | 119 m² | 1 · 103 m² | 18.1 m · 5 |